The Fecal Microbiota Profile and Bronchiolitis in Infants
- PMID: 27354456
- PMCID: PMC4925084
- DOI: 10.1542/peds.2016-0218
The Fecal Microbiota Profile and Bronchiolitis in Infants
Abstract
Background: Little is known about the association of gut microbiota, a potentially modifiable factor, with bronchiolitis in infants. We aimed to determine the association of fecal microbiota with bronchiolitis in infants.
Methods: We conducted a case-control study. As a part of multicenter prospective study, we collected stool samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 115 age-matched healthy controls. By applying 16S rRNA gene sequencing and an unbiased clustering approach to these 155 fecal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis.
Results: Overall, the median age was 3 months, 55% were male, and 54% were non-Hispanic white. Unbiased clustering of fecal microbiota identified 4 distinct profiles: Escherichia-dominant profile (30%), Bifidobacterium-dominant profile (21%), Enterobacter/Veillonella-dominant profile (22%), and Bacteroides-dominant profile (28%). The proportion of bronchiolitis was lowest in infants with the Enterobacter/Veillonella-dominant profile (15%) and highest in the Bacteroides-dominant profile (44%), corresponding to an odds ratio of 4.59 (95% confidence interval, 1.58-15.5; P = .008). In the multivariable model, the significant association between the Bacteroides-dominant profile and a greater likelihood of bronchiolitis persisted (odds ratio for comparison with the Enterobacter/Veillonella-dominant profile, 4.24; 95% confidence interval, 1.56-12.0; P = .005). In contrast, the likelihood of bronchiolitis in infants with the Escherichia-dominant or Bifidobacterium-dominant profile was not significantly different compared with those with the Enterobacter/Veillonella-dominant profile.
Conclusions: In this case-control study, we identified 4 distinct fecal microbiota profiles in infants. The Bacteroides-dominant profile was associated with a higher likelihood of bronchiolitis.
Copyright © 2016 by the American Academy of Pediatrics.
Conflict of interest statement
Figures
Comment in
-
Do Bacteria in the Gut Set the Stage for Who Gets Viral Bronchiolitis and Its Severity?Pediatrics. 2016 Jul;138(1):e20161377. doi: 10.1542/peds.2016-1377. Pediatrics. 2016. PMID: 27354455 Free PMC article. No abstract available.
Similar articles
-
Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study.Pediatr Infect Dis J. 2017 Nov;36(11):1044-1051. doi: 10.1097/INF.0000000000001500. Pediatr Infect Dis J. 2017. PMID: 28005692 Free PMC article.
-
Association of Maternal Gestational Weight Gain With the Infant Fecal Microbiota.J Pediatr Gastroenterol Nutr. 2017 Nov;65(5):509-515. doi: 10.1097/MPG.0000000000001566. J Pediatr Gastroenterol Nutr. 2017. PMID: 28272161 Free PMC article.
-
Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case-control study.BMC Res Notes. 2017 Jul 26;10(1):325. doi: 10.1186/s13104-017-2659-9. BMC Res Notes. 2017. PMID: 28747215 Free PMC article.
-
Comparative Fecal Microbiota Analysis of Infants With Acute Bronchiolitis Caused or Not Caused by Respiratory Syncytial Virus.Front Cell Infect Microbiol. 2022 Mar 7;12:815715. doi: 10.3389/fcimb.2022.815715. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35330643 Free PMC article.
-
Household siblings and nasal and fecal microbiota in infants.Pediatr Int. 2017 Apr;59(4):473-481. doi: 10.1111/ped.13168. Epub 2016 Dec 22. Pediatr Int. 2017. PMID: 27638139 Free PMC article.
Cited by
-
Intrapartum antibiotic exposure and infectious diseases in childhood - a population-based cohort study.EBioMedicine. 2024 Nov;109:105426. doi: 10.1016/j.ebiom.2024.105426. Epub 2024 Oct 31. EBioMedicine. 2024. PMID: 39481208 Free PMC article.
-
Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?Microbiol Spectr. 2024 Jul 2;12(7):e0255623. doi: 10.1128/spectrum.02556-23. Epub 2024 May 24. Microbiol Spectr. 2024. PMID: 38785596 Free PMC article.
-
Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis.Front Immunol. 2024 Feb 12;15:1330991. doi: 10.3389/fimmu.2024.1330991. eCollection 2024. Front Immunol. 2024. PMID: 38410509 Free PMC article.
-
Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review.Viruses. 2024 Jan 31;16(2):220. doi: 10.3390/v16020220. Viruses. 2024. PMID: 38399997 Free PMC article. Review.
-
Gut, oral, and nasopharyngeal microbiota dynamics in the clinical course of hospitalized infants with respiratory syncytial virus bronchiolitis.Front Cell Infect Microbiol. 2023 Aug 23;13:1193113. doi: 10.3389/fcimb.2023.1193113. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37680746 Free PMC article.
References
-
- Ralston SL, Lieberthal AS, Meissner HC, et al. ; American Academy of Pediatrics . Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5). Available at: www.pediatrics.org/cgi/content/full/134/5/e1474 - PubMed
-
- Hasegawa K, Mansbach JM, Camargo CA Jr. Infectious pathogens and bronchiolitis outcomes. Expert Rev Anti Infect Ther. 2014;12(7):817–828 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
